{"id":24170,"date":"2025-11-21T16:52:56","date_gmt":"2025-11-21T16:52:56","guid":{"rendered":"https:\/\/beonemedicines.ca\/fr\/?page_id=24170"},"modified":"2025-12-11T15:20:23","modified_gmt":"2025-12-11T15:20:23","slug":"nouvelles","status":"publish","type":"page","link":"https:\/\/beonemedicines.ca\/fr\/nouvelles\/","title":{"rendered":"Nouvelles"},"content":{"rendered":"<!-- Hero | Interior with image -->\r\n<section class=\"hero-interior-sec card-image-right bg-tertiary-light overflow-x-clip \">\r\n    <div class=\"card-offset-watermark watermark-leftbotttom d-none d-md-block\">\r\n        <img decoding=\"async\" src=\"https:\/\/beonemedicines.ca\/fr\/wp-content\/themes\/beigene20\/assets\/img\/cutoutStar-icon.svg\" alt=\"Watermark\">\r\n    <\/div>\r\n    <div class=\"container offset-left container-offset\">\r\n        <div class=\"row\">\r\n            <div class=\"col-md-6 card-content-col\">\r\n                <div class=\"card-offset-watermark watermark-leftbotttom d-md-none\">\r\n                    <img decoding=\"async\" src=\"https:\/\/beonemedicines.ca\/fr\/wp-content\/themes\/beigene20\/assets\/img\/cutoutStar-icon.svg\" alt=\"Watermark\">\r\n                <\/div>\r\n                <div class=\"card-offset-box\">\r\n                    <div class=\"card-heading\">\r\n                                                \r\n                        <h1 class=\"anim fadeInUp\">Salle de presse BeOne<\/h1>\r\n                    <\/div>\r\n                    <div class=\"card-bodycopy\">                        \r\n                                                                        \r\n                    <\/div>\r\n\r\n                    \r\n                    \r\n                    \r\n                <\/div>\r\n            <\/div>\r\n\r\n            <div class=\"col-md-6 card-img-col\">\r\n                <div class=\"card-offset-img\">\r\n                    <img decoding=\"async\" src=\"https:\/\/beonemedicines.ca\/fr\/wp-content\/uploads\/sites\/4\/2025\/03\/newsroom-banner.jpg\" alt=\"Newsroom Hero\">\r\n                <\/div>\r\n            <\/div>\r\n            \t\t\t\t\t\r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n<!-- Hero | Interior with image -->\n\n<!-- Card Set | Vertical list -->\r\n<section class=\"card-set-vertical-list \"\r\n         data-posts-per-page=\"12\" \r\n         data-latest-post=\"true\" \r\n         data-show-date=\"true\" \r\n         data-post-ids=\"\">\r\n    <div class=\"container\">\r\n        <div class=\"row\">\r\n            <div class=\"col-md-12 col-lg-9\">\r\n                <div class=\"card-set-vertical-inner\">\r\n                    <div class=\"sec-header\">\r\n                        <div class=\"sec-head anim fadeInUp\">\r\n                            <h2>Communiqu\u00e9s de presse<\/h2>\r\n                        <\/div>\r\n                                                <div class=\"sec-body anim fadeInUp\">\r\n                            <p>Lisez nos derni\u00e8res actualit\u00e9s.<\/p>\n                        <\/div>\r\n                                            <\/div>\r\n                <\/div>\r\n            <\/div>\r\n            <div class=\"col-md-12 col-lg-12\">\r\n                    <div class=\"card-set-content row-tm-60 anim fadeInUp\">\r\n                        <ul class=\"card-set-items\" id=\"content-pressreleases-list\">\r\n                                                            <li class=\"card-set-item external-\" external-url=\"\">\r\n                                    <a href=\"https:\/\/beonemedicines.ca\/fr\/pressreleases\/sante-canada-approuve-lutilisation-de-tevimbra-tislelizumab-pour-injection-en-association-avec-la-gemcitabine-et-le-cisplatine-pour-le-traitement-de-premiere-ligne-des-patients-adulte\/\" >\r\n\r\n                                                                                <div class=\"card-set-date\">\r\n                                            <h6>December 23, 2025<\/h6>\r\n                                        <\/div>\r\n                                                                                <div class=\"card-set-title\">\r\n                                            <h4>\r\n                                                Sant\u00e9 Canada approuve l\u2019utilisation de TEVIMBRA\u00ae (tisl\u00e9lizumab pour injection) en association avec la gemcitabine et le cisplatine pour le traitement de premi\u00e8re ligne des patients adultes pr\u00e9sentant un carcinome nasopharyng\u00e9 (CNP) r\u00e9current ou m\u00e9tastatique.                                                                                            <\/h4>\r\n                                            <!-- Icon change based on external link condition -->\r\n                                                                                            <span class=\"card-icon-link link-internal\">                                                     \r\n                                                    <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                                        <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"\/>\r\n                                                    <\/svg>\r\n                                                <\/span>\r\n                                                                                    <\/div>\r\n                                    <\/a>\r\n                                <\/li>\r\n                                \r\n                                                            <li class=\"card-set-item external-\" external-url=\"\">\r\n                                    <a href=\"https:\/\/beonemedicines.ca\/fr\/pressreleases\/beone-medicines-launches-following-redomiciliation-to-switzerland-marking-a-new-chapter-in-global-oncology\/\" >\r\n\r\n                                                                                <div class=\"card-set-date\">\r\n                                            <h6>May 27, 2025<\/h6>\r\n                                        <\/div>\r\n                                                                                <div class=\"card-set-title\">\r\n                                            <h4>\r\n                                                BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology                                                                                            <\/h4>\r\n                                            <!-- Icon change based on external link condition -->\r\n                                                                                            <span class=\"card-icon-link link-internal\">                                                     \r\n                                                    <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                                        <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"\/>\r\n                                                    <\/svg>\r\n                                                <\/span>\r\n                                                                                    <\/div>\r\n                                    <\/a>\r\n                                <\/li>\r\n                                \r\n                                                            <li class=\"card-set-item external-\" external-url=\"\">\r\n                                    <a href=\"https:\/\/beonemedicines.ca\/fr\/pressreleases\/beigene-canada-est-fiere-detre-commanditaire-national-de-levenement-illumine-la-nuit-2024-de-la-societe-de-leucemie-et-lymphome-du-canada\/\" >\r\n\r\n                                                                                <div class=\"card-set-date\">\r\n                                            <h6>October 29, 2024<\/h6>\r\n                                        <\/div>\r\n                                                                                <div class=\"card-set-title\">\r\n                                            <h4>\r\n                                                BeiGene Canada est fi\u00e8re d&#8217;\u00eatre commanditaire national de l&#8217;\u00e9v\u00e9nement Illumine la nuit 2024 de la Soci\u00e9t\u00e9 de leuc\u00e9mie et lymphome du Canada                                                                                            <\/h4>\r\n                                            <!-- Icon change based on external link condition -->\r\n                                                                                            <span class=\"card-icon-link link-internal\">                                                     \r\n                                                    <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                                        <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"\/>\r\n                                                    <\/svg>\r\n                                                <\/span>\r\n                                                                                    <\/div>\r\n                                    <\/a>\r\n                                <\/li>\r\n                                \r\n                                                            <li class=\"card-set-item external-\" external-url=\"\">\r\n                                    <a href=\"https:\/\/beonemedicines.ca\/fr\/pressreleases\/un-chef-de-file-du-secteur-de-la-biotechnologie-beigene-ouvre-un-bureau-a-toronto-au-canada\/\" >\r\n\r\n                                                                                <div class=\"card-set-date\">\r\n                                            <h6>May 8, 2024<\/h6>\r\n                                        <\/div>\r\n                                                                                <div class=\"card-set-title\">\r\n                                            <h4>\r\n                                                Un chef de file du secteur de la biotechnologie, BeiGene, ouvre un bureau \u00e0 Toronto, au Canada                                                                                            <\/h4>\r\n                                            <!-- Icon change based on external link condition -->\r\n                                                                                            <span class=\"card-icon-link link-internal\">                                                     \r\n                                                    <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                                        <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"\/>\r\n                                                    <\/svg>\r\n                                                <\/span>\r\n                                                                                    <\/div>\r\n                                    <\/a>\r\n                                <\/li>\r\n                                \r\n                                                            <li class=\"card-set-item external-\" external-url=\"\">\r\n                                    <a href=\"https:\/\/beonemedicines.ca\/fr\/pressreleases\/sante-canada-autorise-brukinsa-zanubrutinib-pour-le-traitement-de-la-leucemie-lymphoide-chronique-llc-la-leucemie-la-plus-frequente-chez-les-adultes-2\/\" >\r\n\r\n                                                                                <div class=\"card-set-date\">\r\n                                            <h6>February 7, 2024<\/h6>\r\n                                        <\/div>\r\n                                                                                <div class=\"card-set-title\">\r\n                                            <h4>\r\n                                                Sant\u00e9 Canada approuve BRUKINSA\u00ae (zanubrutinib) dans le traitement du lymphome folliculaire r\u00e9cidivant ou r\u00e9fractaire                                                                                            <\/h4>\r\n                                            <!-- Icon change based on external link condition -->\r\n                                                                                            <span class=\"card-icon-link link-internal\">                                                     \r\n                                                    <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                                        <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"\/>\r\n                                                    <\/svg>\r\n                                                <\/span>\r\n                                                                                    <\/div>\r\n                                    <\/a>\r\n                                <\/li>\r\n                                \r\n                                                            <li class=\"card-set-item external-\" external-url=\"\">\r\n                                    <a href=\"https:\/\/beonemedicines.ca\/fr\/pressreleases\/les-adultes-atteints-de-leucemie-lymphoide-chronique-llc-de-lontario-et-du-quebec-ont-desormais-acces-a-brukinsa-zanubrutinib-grace-a-un-remboursement-par-le-regime-public\/\" >\r\n\r\n                                                                                <div class=\"card-set-date\">\r\n                                            <h6>January 31, 2024<\/h6>\r\n                                        <\/div>\r\n                                                                                <div class=\"card-set-title\">\r\n                                            <h4>\r\n                                                Les adultes atteints de leuc\u00e9mie lympho\u00efde chronique (LLC) de l&#8217;Ontario et du Qu\u00e9bec ont d\u00e9sormais acc\u00e8s \u00e0 BRUKINSA\u00ae (zanubrutinib) gr\u00e2ce \u00e0 un remboursement par le r\u00e9gime public                                                                                            <\/h4>\r\n                                            <!-- Icon change based on external link condition -->\r\n                                                                                            <span class=\"card-icon-link link-internal\">                                                     \r\n                                                    <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                                        <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"\/>\r\n                                                    <\/svg>\r\n                                                <\/span>\r\n                                                                                    <\/div>\r\n                                    <\/a>\r\n                                <\/li>\r\n                                \r\n                                                            <li class=\"card-set-item external-\" external-url=\"\">\r\n                                    <a href=\"https:\/\/beonemedicines.ca\/fr\/pressreleases\/sante-canada-autorise-brukinsa-zanubrutinib-pour-le-traitement-de-la-leucemie-lymphoide-chronique-llc-la-leucemie-la-plus-frequente-chez-les-adultes\/\" >\r\n\r\n                                                                                <div class=\"card-set-date\">\r\n                                            <h6>May 30, 2023<\/h6>\r\n                                        <\/div>\r\n                                                                                <div class=\"card-set-title\">\r\n                                            <h4>\r\n                                                Sant\u00e9 Canada autorise BRUKINSA (zanubrutinib) pour le traitement de la leuc\u00e9mie lympho\u00efde chronique (LLC), la leuc\u00e9mie la plus fr\u00e9quente chez les adultes\u00a0                                                                                            <\/h4>\r\n                                            <!-- Icon change based on external link condition -->\r\n                                                                                            <span class=\"card-icon-link link-internal\">                                                     \r\n                                                    <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                                        <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"\/>\r\n                                                    <\/svg>\r\n                                                <\/span>\r\n                                                                                    <\/div>\r\n                                    <\/a>\r\n                                <\/li>\r\n                                \r\n                                                            <li class=\"card-set-item external-\" external-url=\"\">\r\n                                    <a href=\"https:\/\/beonemedicines.ca\/fr\/pressreleases\/le-quebec-devient-la-premiere-province-a-rembourser-brukinsa-zanubrutinib-pour-le-traitement-de-la-macroglobulinemie-de-waldenstrom\/\" >\r\n\r\n                                                                                <div class=\"card-set-date\">\r\n                                            <h6>February 6, 2023<\/h6>\r\n                                        <\/div>\r\n                                                                                <div class=\"card-set-title\">\r\n                                            <h4>\r\n                                                Le Qu\u00e9bec devient la premi\u00e8re province \u00e0 rembourser BRUKINSA\u00ae (zanubrutinib) pour le traitement de la macroglobulin\u00e9mie de Waldenstr\u00f6m                                                                                            <\/h4>\r\n                                            <!-- Icon change based on external link condition -->\r\n                                                                                            <span class=\"card-icon-link link-internal\">                                                     \r\n                                                    <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                                        <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"\/>\r\n                                                    <\/svg>\r\n                                                <\/span>\r\n                                                                                    <\/div>\r\n                                    <\/a>\r\n                                <\/li>\r\n                                \r\n                                                            <li class=\"card-set-item external-\" external-url=\"\">\r\n                                    <a href=\"https:\/\/beonemedicines.ca\/fr\/pressreleases\/beigene-canada-nommee-lun-des-meilleurs-lieux-de-travailmc\/\" >\r\n\r\n                                                                                <div class=\"card-set-date\">\r\n                                            <h6>January 9, 2023<\/h6>\r\n                                        <\/div>\r\n                                                                                <div class=\"card-set-title\">\r\n                                            <h4>\r\n                                                BeiGene Canada nomm\u00e9e l&#8217;un des Meilleurs lieux de travail(MC)                                                                                            <\/h4>\r\n                                            <!-- Icon change based on external link condition -->\r\n                                                                                            <span class=\"card-icon-link link-internal\">                                                     \r\n                                                    <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                                        <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"\/>\r\n                                                    <\/svg>\r\n                                                <\/span>\r\n                                                                                    <\/div>\r\n                                    <\/a>\r\n                                <\/li>\r\n                                \r\n                                                            <li class=\"card-set-item external-\" external-url=\"\">\r\n                                    <a href=\"https:\/\/beonemedicines.ca\/fr\/pressreleases\/beigene-met-en-marche-brukinsa-zanubrutinib-pour-le-traitement-de-la-macroglobulinemie-de-waldenstrom\/\" >\r\n\r\n                                                                                <div class=\"card-set-date\">\r\n                                            <h6>April 8, 2021<\/h6>\r\n                                        <\/div>\r\n                                                                                <div class=\"card-set-title\">\r\n                                            <h4>\r\n                                                BeiGene met en march\u00e9 BRUKINSA\u00ae (zanubrutinib) pour le traitement de la macroglobulin\u00e9mie de Waldenstr\u00f6m                                                                                            <\/h4>\r\n                                            <!-- Icon change based on external link condition -->\r\n                                                                                            <span class=\"card-icon-link link-internal\">                                                     \r\n                                                    <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                                        <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"\/>\r\n                                                    <\/svg>\r\n                                                <\/span>\r\n                                                                                    <\/div>\r\n                                    <\/a>\r\n                                <\/li>\r\n                                \r\n                             \r\n                        <\/ul>\r\n                        \r\n                        <!-- pagination  -->\r\n\r\n                        \r\n\r\n                        <!-- <div class=\"nav-pagination row-tm-60\">\r\n                            <ul class=\"pagination d-flex justify-center align-center\">\r\n                                <li class=\"page-item page-arrow previous-page disabled\">\r\n                                <a class=\"page-link\"><span><svg width=\"7\" height=\"10\" viewBox=\"0 0 7 10\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"> <path d=\"M6 1L2 5L6 9\" stroke=\"currentColor\" stroke-width=\"1.5\"><\/path> <\/svg><\/span><\/a>\r\n                                <\/li>\r\n                                <li class=\"page-item\"><a class=\"page-link active\" href=\"#\">1<\/a><\/li>\r\n                                <li class=\"page-item page-skip page-skip-right\"><a class=\"page-link\" href=\"#\">...<\/a><\/li>\r\n                                <li class=\"page-item\"><a class=\"page-link\" href=\"#\">3<\/a><\/li>\r\n                                <li class=\"page-item\"><a class=\"page-link\" href=\"#\">4<\/a><\/li>\r\n                                <li class=\"page-item\"><a class=\"page-link\" href=\"#\">5<\/a><\/li>\r\n                                <li class=\"page-item page-skip\"><a class=\"page-link\" href=\"#\">...<\/a><\/li>\r\n                                <li class=\"page-item\"><a class=\"page-link\" href=\"#\">10<\/a><\/li>\r\n                                <li class=\"page-item page-arrow next-page\">\r\n                                <a class=\"page-link\" href=\"#\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"8\" height=\"12\" viewBox=\"0 0 8 12\" fill=\"none\">\r\n                                    <path d=\"M1 1L6 6L1 11\" stroke=\"currentColor\" stroke-width=\"1.5\"><\/path>\r\n                                    <\/svg><\/a>\r\n                                <\/li>\r\n                            <\/ul>\r\n                        <\/div> -->\r\n                        <!-- pagination  -->\r\n\r\n                        \r\n                         <!-- Card Set Button-->    \r\n                                          \r\n                             \r\n                                <div class=\"card-buttons row-tm-60\">\r\n                                                                    \r\n                                        <a href=\"https:\/\/ir.beonemedicines.com\/news-events\/pressreleases\/\" target=\"_blank\" class=\"btn-default btn-primary btn-exLinks \">\r\n                                            <span>\u00e0 Voir tous les communiqu\u00e9s de presse<\/span>\r\n                                        <\/a>\r\n                                                                                                    <\/div>\r\n                                                                           \r\n                        \r\n                    <\/div>\r\n            <\/div>\r\n        <\/div>\r\n    <\/div>\r\n<\/section>\r\n<!-- Card Set | Vertical list -->\r\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-24170","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nouvelles - BeOne Medicines FR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beonemedicines.ca\/fr\/nouvelles\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nouvelles - BeOne Medicines FR\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beonemedicines.ca\/fr\/nouvelles\/\" \/>\n<meta property=\"og:site_name\" content=\"BeOne Medicines FR\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-11T15:20:23+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/beonemedicines.ca\\\/fr\\\/nouvelles\\\/\",\"url\":\"https:\\\/\\\/beonemedicines.ca\\\/fr\\\/nouvelles\\\/\",\"name\":\"Nouvelles - BeOne Medicines FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/beonemedicines.ca\\\/fr\\\/#website\"},\"datePublished\":\"2025-11-21T16:52:56+00:00\",\"dateModified\":\"2025-12-11T15:20:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/beonemedicines.ca\\\/fr\\\/nouvelles\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/beonemedicines.ca\\\/fr\\\/nouvelles\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/beonemedicines.ca\\\/fr\\\/nouvelles\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/beonemedicines.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nouvelles\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/beonemedicines.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/beonemedicines.ca\\\/fr\\\/\",\"name\":\"BeOne Medicines FR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/beonemedicines.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nouvelles - BeOne Medicines FR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beonemedicines.ca\/fr\/nouvelles\/","og_locale":"en_US","og_type":"article","og_title":"Nouvelles - BeOne Medicines FR","og_url":"https:\/\/beonemedicines.ca\/fr\/nouvelles\/","og_site_name":"BeOne Medicines FR","article_modified_time":"2025-12-11T15:20:23+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beonemedicines.ca\/fr\/nouvelles\/","url":"https:\/\/beonemedicines.ca\/fr\/nouvelles\/","name":"Nouvelles - BeOne Medicines FR","isPartOf":{"@id":"https:\/\/beonemedicines.ca\/fr\/#website"},"datePublished":"2025-11-21T16:52:56+00:00","dateModified":"2025-12-11T15:20:23+00:00","breadcrumb":{"@id":"https:\/\/beonemedicines.ca\/fr\/nouvelles\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beonemedicines.ca\/fr\/nouvelles\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/beonemedicines.ca\/fr\/nouvelles\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beonemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Nouvelles"}]},{"@type":"WebSite","@id":"https:\/\/beonemedicines.ca\/fr\/#website","url":"https:\/\/beonemedicines.ca\/fr\/","name":"BeOne Medicines FR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beonemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/beonemedicines.ca\/fr\/wp-json\/wp\/v2\/pages\/24170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedicines.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/beonemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/beonemedicines.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/beonemedicines.ca\/fr\/wp-json\/wp\/v2\/comments?post=24170"}],"version-history":[{"count":6,"href":"https:\/\/beonemedicines.ca\/fr\/wp-json\/wp\/v2\/pages\/24170\/revisions"}],"predecessor-version":[{"id":24257,"href":"https:\/\/beonemedicines.ca\/fr\/wp-json\/wp\/v2\/pages\/24170\/revisions\/24257"}],"wp:attachment":[{"href":"https:\/\/beonemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=24170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}